Rho-Kinase-IN-2 (Compound 23) is an orally active and selective inhibitor of RhoKinase (ROCK), which can penetrate the central nervous system (CNS). It exhibits a high affinity for ROCK2 with an inhibition constant (IC50) of 3 nM. This compound is of potential interest for further investigations in the field of Huntington's disease research [1].